Genentech/Roche — Drug Prices & Medicare Spending

Genentech/Roche manufactures 22 drugs tracked by Medicare Part D with total spending of $17.0B.

Drugs Tracked

$17.0B

Medicare Spending

$1,447.90

Avg Cost/Claim

100%

Have Generics

Genentech/Roche Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Ocrevus	Ocrelizumab	$23,635.00	$3.5B	+16.5%	Yes
2	Tecentriq	Atezolizumab	$10,847.00	$1.3B	+12.8%	Yes
3	Vabysmo	Faricimab	$663.00	$1.2B	+156.3%	Yes
4	Perjeta	Pertuzumab	$12,592.00	$1.2B	-5.6%	Yes
5	Hemlibra	Emicizumab	$34,278.00	$1.2B	+18.6%	Yes
6	Lucentis	Ranibizumab	$654.00	$1.1B	-22.3%	Yes
7	Kadcyla	Ado-Trastuzumab Emtansine	$14,515.00	$987.0M	-8.2%	Yes
8	Actemra	Tocilizumab	$5,306.00	$987.0M	+6.2%	Yes
9	Rituxan	Rituximab	$3,980.00	$987.0M	-18.6%	Yes
10	Alecensa	Alectinib	$12,882.00	$876.0M	+12.4%	Yes
11	Gazyva	Obinutuzumab	$11,813.00	$567.0M	+4.2%	Yes
12	Evrysdi	Risdiplam	$31,500.00	$567.0M	+42.6%	Yes
13	Avastin	Bevacizumab	$3,831.00	$567.0M	-22.4%	Yes
14	Herceptin	Trastuzumab	$3,677.00	$456.0M	-28.6%	Yes
15	CellCept	Mycophenolate Mofetil	$139.00	$345.0M	-18.6%	Yes
16	Oseltamivir	Oseltamivir Phosphate	$72.00	$178.0M	+12.4%	Yes
17	Tarceva	Erlotinib	$7,417.00	$178.0M	-24.4%	Yes
18	Rozlytrek	Entrectinib	$14,833.00	$178.0M	+18.6%	Yes
19	Gavreto	Pralsetinib	$14,833.00	$178.0M	+28.4%	Yes
20	Zelboraf	Vemurafenib	$10,250.00	$123.0M	-14.6%	Yes
21	Cotellic	Cobimetinib	$10,250.00	$123.0M	-8.4%	Yes
22	Ibandronate	Ibandronate Sodium	$36.00	$67.0M	-28.6%	Yes

Genentech/Roche manufactures 22 drugs tracked by Medicare Part D, with total annual spending of $17.0B.

Hemlibra (Emicizumab) is the most expensive at $34,278.00 per claim.

22 of 22 Genentech/Roche drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.